2025. Lebrikizumab Treatment Improves Lichenification and Other Clinical Signs of Atopic Dermatitis in Adults and Adolescents with Moderate-to-Severe AD and Skin of Color. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s625. DOI:https://doi.org/10.25251/0262jz84.